Jorge Darcourt

1.4k total citations
20 papers, 923 citations indexed

About

Jorge Darcourt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jorge Darcourt has authored 20 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Jorge Darcourt's work include Cancer Treatment and Pharmacology (4 papers), Advanced Breast Cancer Therapies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Jorge Darcourt is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Advanced Breast Cancer Therapies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Jorge Darcourt collaborates with scholars based in United States, China and France. Jorge Darcourt's co-authors include A. Clinton White, Richard J. Hamill, Samuel A. Shelburne, Fehmida Visnegarwala, Edward A. Graviss, Thomas P. Giordano, Robert L. Atmar, Stephen B. Greenberg, Joe Ensor and Jenny C. Chang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jorge Darcourt

19 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Darcourt United States 9 505 331 323 217 105 20 923
Eli Serur United States 14 487 1.0× 114 0.3× 299 0.9× 265 1.2× 51 0.5× 38 960
V. Delcey France 14 385 0.8× 302 0.9× 261 0.8× 86 0.4× 36 0.3× 29 770
George Moussa United Kingdom 18 1.0k 2.0× 269 0.8× 209 0.6× 362 1.7× 61 0.6× 74 1.5k
Marta Calvo Spain 19 698 1.4× 173 0.5× 338 1.0× 56 0.3× 84 0.8× 89 1.3k
Alice Tung Wan Song Brazil 19 321 0.6× 233 0.7× 312 1.0× 69 0.3× 268 2.6× 62 1.3k
Salvatrice Mancuso Italy 19 222 0.4× 198 0.6× 128 0.4× 260 1.2× 248 2.4× 71 1.1k
Jesús Santos Spain 14 267 0.5× 270 0.8× 119 0.4× 135 0.6× 37 0.4× 44 668
Erin Amerson United States 12 185 0.4× 283 0.9× 145 0.4× 179 0.8× 64 0.6× 42 841
W.J. van Son Netherlands 16 760 1.5× 123 0.4× 146 0.5× 106 0.5× 92 0.9× 42 1.1k
Seyed M. Hosseini‐Moghaddam Canada 18 571 1.1× 412 1.2× 139 0.4× 118 0.5× 139 1.3× 58 1.1k

Countries citing papers authored by Jorge Darcourt

Since Specialization
Citations

This map shows the geographic impact of Jorge Darcourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Darcourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Darcourt more than expected).

Fields of papers citing papers by Jorge Darcourt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Darcourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Darcourt. The network helps show where Jorge Darcourt may publish in the future.

Co-authorship network of co-authors of Jorge Darcourt

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Darcourt. A scholar is included among the top collaborators of Jorge Darcourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Darcourt. Jorge Darcourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Messer, J.A., Waqar Haque, Andrew Farach, et al.. (2023). Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer. Clinical and Translational Radiation Oncology. 39. 100592–100592. 4 indexed citations
2.
Niravath, Polly, Joe Ensor, Tejal Patel, et al.. (2021). ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer. Breast Cancer Research and Treatment. 188(2). 433–439. 6 indexed citations
3.
Anand, Kartik, Tejal Patel, Polly Niravath, et al.. (2021). Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy. Scientific Reports. 11(1). 82–82. 25 indexed citations
4.
Ensor, Joe, Andrew Farach, Sindhu Nair, et al.. (2021). Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer.. Journal of Clinical Oncology. 39(15_suppl). 9115–9115. 7 indexed citations
5.
Darcourt, Jorge, Joe Ensor, Eva Zsigmond, et al.. (2020). Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic. JCO Oncology Practice. 17(1). e36–e43. 80 indexed citations
6.
Burns, Ethan, Ibrahim N. Muhsen, John Rogers, et al.. (2020). Primary and Secondary Central Nervous System Lymphoma: Outcomes from Houston Methodist Cancer Center. Blood. 136(Supplement 1). 16–17.
7.
8.
Eterovic, Agda Karina, Joe Ensor, Helen J. Huang, et al.. (2019). Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases. Breast Cancer Research and Treatment. 178(2). 251–261. 13 indexed citations
9.
Haque, Waqar, Vivek Verma, Monty Aghazadeh, et al.. (2019). Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer. Clinical Genitourinary Cancer. 17(5). e1069–e1079. 8 indexed citations
10.
11.
Ensor, Joe, Jorge Darcourt, Anna Belcheva, et al.. (2019). Abstract CT052: A Phase Ib and II clinical trial investigating the efficacy of nitric oxide deprivation and docetaxel in triple negative breast cancer. Cancer Research. 79(13_Supplement). CT052–CT052. 3 indexed citations
12.
Niravath, Polly, Joe Ensor, Tejal Patel, et al.. (2019). Open label, phase II trial of neoadjuvant TAK-228 plus tamoxifen in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor type 2 (HER2)-negative breast cancer-ANETT.. Journal of Clinical Oncology. 37(15_suppl). 584–584. 2 indexed citations
13.
Patel, Tejal, Joe Ensor, Angel Rodriguez, et al.. (2018). Phase ib study of trastuzumab emtansine (TDM1) in combination with lapatinib and nab-paclitaxel in metastatic HER2-neu overexpressed breast cancer patients: Stela results.. Journal of Clinical Oncology. 36(15_suppl). 1035–1035. 11 indexed citations
14.
15.
Haque, Waqar, Gary D. Lewis, Vivek Verma, et al.. (2017). The role of adjuvant chemotherapy in locally advanced bladder cancer. Acta Oncologica. 57(4). 509–515. 21 indexed citations
16.
Shelburne, Samuel A., Jorge Darcourt, A. Clinton White, et al.. (2005). The Role of Immune Reconstitution Inflammatory Syndrome in AIDS‐RelatedCryptococcus neoformansDisease in the Era of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 40(7). 1049–1052. 221 indexed citations
17.
Shelburne, Samuel A., Fehmida Visnegarwala, Jorge Darcourt, et al.. (2005). Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 19(4). 399–406. 464 indexed citations
18.
Diggles, L., et al.. (1993). THE USE OF TEXTURE ANALYSIS METHOD TO FACILITATE DETECTION OF BREAST CARCINOMA IN SCINTIGRAPHIC IMAGES. Clinical Nuclear Medicine. 18(10). 927–927. 3 indexed citations
19.
Santini, J., O. Dassonville, Carla Serra, et al.. (1989). [Intra-arterial chemotherapy of ORL cancer. Value of an implantable infusion system and scintigraphic monitoring].. PubMed. 106(8). 557–60. 1 indexed citations
20.
Jl, Lagrange, A. Courdi, Jorge Darcourt, et al.. (1988). [Breast cancer: the role of scintigraphy in the initial evaluation and follow-up of patients with small tumors (T less than or equal to 3 cm)].. PubMed. 75(3). 271–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eli Serur Breakdown of academic impact, for papers by V. Delcey Breakdown of academic impact, for papers by George Moussa Breakdown of academic impact, for papers by Marta Calvo Breakdown of academic impact, for papers by Alice Tung Wan Song Breakdown of academic impact, for papers by Salvatrice Mancuso Breakdown of academic impact, for papers by Jesús Santos Breakdown of academic impact, for papers by Erin Amerson Breakdown of academic impact, for papers by W.J. van Son Breakdown of academic impact, for papers by Seyed M. Hosseini‐Moghaddam
Rankless by CCL
2026